{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T05:11:33Z","timestamp":1697433093582},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2006,11,23]],"date-time":"2006-11-23T00:00:00Z","timestamp":1164240000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Fam Pract"],"published-print":{"date-parts":[[2006,12]]},"DOI":"10.1186\/1471-2296-7-69","type":"journal-article","created":{"date-parts":[[2006,11,23]],"date-time":"2006-11-23T14:15:57Z","timestamp":1164291357000},"source":"Crossref","is-referenced-by-count":5,"title":["Changes in heart failure medications in patients hospitalised and discharged"],"prefix":"10.1186","volume":"7","author":[{"given":"Martin","family":"Scherer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cordula","family":"Sobek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirk","family":"Wetzel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janka","family":"Koschack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael M","family":"Kochen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,11,23]]},"reference":[{"key":"200_CR1","doi-asserted-by":"publisher","first-page":"2996","DOI":"10.1161\/hc4901.102568","volume":"104","author":"ACC\/AHA Task Force on Practice Guideline","year":"2001","unstructured":"ACC\/AHA Task Force on Practice Guideline: ACC\/AHA guidelines for the evaluation and management of chronic heart failure in the adult. Executive summary. Circulation. 2001, 104: 2996-3007.","journal-title":"Circulation"},{"key":"200_CR2","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1007\/s003920170187","volume":"90","author":"UC Hoppe","year":"2001","unstructured":"Hoppe UC, Erdmann E, for the Commission of Clinical Cardiology, German Society of Cardiology-Heart-and Circulation Research: Guidelines for treatment of chronic heart failure [in German]. Z Kardiol. 2001, 90: 218-241. 10.1007\/s003920170187.","journal-title":"Z Kardiol"},{"key":"200_CR3","unstructured":"Evidence-based guideline for diagnostics and treatment of the Science Network \u201eevidence.de\" of the University of Witten\/Herdecke [in German]. (Accessed 27 May 2006), [\n                    http:\/\/www.evidence.de\n                    \n                  ]"},{"key":"200_CR4","unstructured":"Treatment of chronic heart failure [in German]. (Accessed 27 May 2006), [\n                    http:\/\/www.uni-duesseldorf.de\/WWW\/AWMF\n                    \n                  ]"},{"key":"200_CR5","unstructured":"Guideline Group Hessia: General practice guideline chronic heart failure [in German]. Version 2.04. (Accessed 27 May 2006), [\n                    http:\/\/www.pmvforschungsgruppe.de\n                    \n                  ]"},{"key":"200_CR6","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1016\/S0140-6736(97)04442-5","volume":"349","author":"AS Hall","year":"1997","unstructured":"Hall AS, Murray GD, Ball SG: Follow-up study of patients randomly allocated ramipril or placebo for heart failure after acute myocardial infarction: AIRE Extension (AIREX) Study. Acute Infarction Ramipril Efficacy. Lancet. 1997, 349: 1493-1497. 10.1016\/S0140-6736(97)04442-5.","journal-title":"Lancet"},{"key":"200_CR7","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1016\/0002-9149(91)90280-X","volume":"68","author":"WB Hood Jr","year":"1991","unstructured":"Hood WB, Youngblood M, Ghali JK, Reid M, Rogers WJ, Howe D, Teo KK, LeJemtel TH: Initial blood pressure response to enalapril in hospitalized patients (Studies of Left Ventricular Dysfunction [SOLVD]). Am J Cardiol. 1991, 68: 1465-1468. 10.1016\/0002-9149(91)90280-X.","journal-title":"Am J Cardiol"},{"key":"200_CR8","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1161\/01.CIR.100.10.1056","volume":"100","author":"RS McKelvie","year":"1999","unstructured":"McKelvie RS, Yusuf S, Pericak D, Avezum A, Burns RJ, Probstfield J, Tsuyuki RT, White M, Rouleau J, Latini R, Maggioni A, Young J, Pogue J: Comparison of candesartan, enalapril, and their combination in congestive heart failure: randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study. The RESOLVD Pilot Study Investigators. Circulation. 1999, 100: 1056-1064.","journal-title":"Circulation"},{"key":"200_CR9","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1016\/S0140-6736(00)02213-3","volume":"355","author":"B Pitt","year":"2000","unstructured":"Pitt B, Poole-Wilson PA, Segal R, Martinez FA, Dickstein K, Camm AJ, Konstam MA, Riegger G, Klinger GH, Neaton J, Sharma D, Thiyagarajan B: Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial-the Losartan Heart Failure Survival Study ELITE II. Lancet. 2000, 355: 1582-1587. 10.1016\/S0140-6736(00)02213-3.","journal-title":"Lancet"},{"key":"200_CR10","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1016\/S0140-6736(99)04440-2","volume":"353","author":"MERIT-HF Study Group","year":"1999","unstructured":"MERIT-HF Study Group: Effect of metoprolol CR\/XL in chronic heart failure: Metoprolol CR\/XL Randomised Intervention Trial in congestive Heart Failure. (Merit-HF). Lancet. 1999, 353: 2001-2007. 10.1016\/S0140-6736(99)04440-2.","journal-title":"Lancet"},{"key":"200_CR11","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0140-6736(98)11181-9","volume":"353","author":"CIBIS-II-Research-Group","year":"1999","unstructured":"CIBIS-II-Research-Group: The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet. 1999, 353: 9-13. 10.1016\/S0140-6736(98)11181-9.","journal-title":"Lancet"},{"key":"200_CR12","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1161\/01.CIR.98.12.1184","volume":"8","author":"P Lechat","year":"1998","unstructured":"Lechat P, Packer M, Chalon S, Cucherat M, Arab T, Boissel JP: Clinical effects of beta-adrenergic blockade in chronic heart failure: a meta-analysis of double-blind, placebo-controlled, randomized trials. Circulation. 1998, 8: 1184-191.","journal-title":"Circulation"},{"key":"200_CR13","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/S0002-9149(00)00729-3","volume":"85","author":"FJ Ramires","year":"2000","unstructured":"Ramires FJ, Mansur A, Coelho O, Maranhao M, Gruppi CJ, Mady C, Ramires JA: Effect of spironolactone on ventricular arrhythmias in congestive heart failure secondary to idiopathic dilated or to ischemic cardiomyopathy. Am J Cardiol. 2000, 85: 1207-1211. 10.1016\/S0002-9149(00)00729-3.","journal-title":"Am J Cardiol"},{"key":"200_CR14","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1056\/NEJM199909023411001","volume":"34","author":"B Pitt","year":"1999","unstructured":"Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J: The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomised Aldactone Evaluation Study Investigators. N Engl J Med. 1999, 34: 709-717. 10.1056\/NEJM199909023411001.","journal-title":"N Engl J Med"},{"key":"200_CR15","first-page":"78","volume":"181","author":"SM Phillips","year":"2004","unstructured":"Phillips SM, Marton RL, Tofler GH: Barriers to diagnosing and managing heart failure in primary care. MJA. 2004, 181: 78-81.","journal-title":"MJA"},{"key":"200_CR16","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.2165\/00003495-200161140-00002","volume":"61","author":"TJ Bungard","year":"2001","unstructured":"Bungard TJ, McAlister FA, Johnson JA, Tsuyuki RT: Underutilisation of ACE inhibitors in patients with congestive heart failure. Drugs. 2001, 61: 2021-2033. 10.2165\/00003495-200161140-00002.","journal-title":"Drugs"},{"key":"200_CR17","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/S0002-8703(99)70006-2","volume":"138","author":"DW Baker","year":"1999","unstructured":"Baker DW, Hayes RP, Massie BM, Craig CA: Variations in family physicians' and cardiologists' care for patients with heart failure. Am Heart J. 1999, 138: 826-834. 10.1016\/S0002-8703(99)70006-2.","journal-title":"Am Heart J"},{"key":"200_CR18","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/S1388-9842(01)00233-1","volume":"4","author":"CM Cline","year":"2002","unstructured":"Cline CM, Boman K, Holst M, Erhardt LR, Swedish Society of Cardiology Working Group for Heart Failure: The management of heart failure in Sweden. Eur J Heart Fail. 2002, 4: 373-376.","journal-title":"Eur J Heart Fail"},{"key":"200_CR19","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1136\/pmj.77.914.765","volume":"77","author":"R McMullan","year":"2001","unstructured":"McMullan R, Silke B: A survey of the dose of ACE inhibitors prescribed by general physicians for patients with heart failure. Postgrad Med J. 2001, 77: 765-768. 10.1136\/pmj.77.914.765.","journal-title":"Postgrad Med J"},{"key":"200_CR20","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/S1388-9842(01)00173-8","volume":"3","author":"J McMurray","year":"2001","unstructured":"McMurray J, Cohen-Solal A, Dietz R, Eichhorn E, Erhardt L, Hobbs R, Maggioni A, Pina I, Soler-Soler J, Swedberg K, Clinical Research Initiative in Heart failure: Practical recommendations for the use of ACE inhibitors, beta-blockers and spironolactone in heart failure: putting guidelines into practice. Eur J Heart Fail. 2001, 3: 495-502. 10.1016\/S1388-9842(01)00173-8.","journal-title":"Eur J Heart Fail"},{"key":"200_CR21","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1055\/s-2002-33545","volume":"127","author":"RH B\u00f6ger","year":"2002","unstructured":"B\u00f6ger RH: How is chronic heart failure treated today? [in German]. Dtsch Med Wochenschr. 2002, 127: 1764-1768.","journal-title":"Dtsch Med Wochenschr"},{"key":"200_CR22","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1017\/S0266462300003202","volume":"4","author":"AL Greer","year":"1988","unstructured":"Greer AL: The state of the art versus the state of the science. The diffusion of new medical technologies into practice. Int J Technol Assess Health Care. 1988, 4: 5-26.","journal-title":"Int J Technol Assess Health Care"},{"key":"200_CR23","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1017\/S0266462300003214","volume":"4","author":"DE Kanouse","year":"1988","unstructured":"Kanouse DE, Jacoby I: When does information change practitioners' behavior?. Int J Technol Assess Health Care. 1988, 4: 27-33.","journal-title":"Int J Technol Assess Health Care"},{"key":"200_CR24","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1055\/s-2006-933712","volume":"131","author":"M Scherer","year":"2006","unstructured":"Scherer M, Koschack J, Chenot JF, Sobek C, Wetzel D, Kochen MM: Transformation of general measures by patients in heart failure. [in German]. Dtsch Med Wochenschr. 2006, 131: 667-671. 10.1055\/s-2006-933712.","journal-title":"Dtsch Med Wochenschr"},{"key":"200_CR25","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1046\/j.1365-2036.2003.01600.x","volume":"17","author":"F Parente","year":"2003","unstructured":"Parente F, Cucino C, Gallus S, Bargiggia S, Greco S, Pastore L, Bianchi Porro G: Hospital use of acid-suppressive medications and its fall-out on prescribing in general practice: a 1-month survey. Aliment Pharmacol Ther. 2003, 17: 1503-1506. 10.1046\/j.1365-2036.2003.01600.x.","journal-title":"Aliment Pharmacol Ther"},{"key":"200_CR26","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1007\/s00228-004-0838-9","volume":"60","author":"S Harder","year":"2005","unstructured":"Harder S, Fischer P, Krause-Schafer M, Ostermann K, Helms G, Prinz H, Hahmann M, Baas H: Structure and markers of appropriateness, quality and performance of drug treatment over a 1-year period after hospital discharge in a cohort of elderly patients with cardiovascular diseases from Germany. Eur J Clin Pharmacol. 2005, 60: 797-805. 10.1007\/s00228-004-0838-9.","journal-title":"Eur J Clin Pharmacol"},{"key":"200_CR27","first-page":"97","volume":"28","author":"C Mas Arcas","year":"2004","unstructured":"Mas Arcas C, Pascual Pla F, Escriva Munz JJ, Boscas Mayans R: Induced drug prescription in oncology patients. Farm Hosp. 2004, 28: 97-100.","journal-title":"Farm Hosp"},{"key":"200_CR28","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/S1388-9842(03)00050-3","volume":"5","author":"FH Rutten","year":"2003","unstructured":"Rutten FH, Grobbee DE, Hoes AW: Differences between general practitioners and cardiologists in diagnosis and management of heart failure: a survey in every-day practice. Eur J Heart Fail. 2003, 5: 337-344. 10.1016\/S1388-9842(03)00050-3.","journal-title":"Eur J Heart Fail"},{"key":"200_CR29","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1053\/euhj.1998.1343","volume":"20","author":"DJ van Veldhuisen","year":"1999","unstructured":"van Veldhuisen DJ, Charlesworth A, Crijns HJ, Lie KI, Hampton JR: Differences in drug treatment of chronic heart failure between European countries. Eur Heart J. 1999, 20: 666-672. 10.1053\/euhj.1998.1343.","journal-title":"Eur Heart J"},{"key":"200_CR30","doi-asserted-by":"publisher","first-page":"77","DOI":"10.5414\/CPP41077","volume":"41","author":"K Taxis","year":"2003","unstructured":"Taxis K, Schneeweiss S: Frequency and predictors of drug therapy interruptions after hospital discharge under physician drug budgets in Germany. Int J Clin Pharmacol Ther. 2003, 41: 77-82.","journal-title":"Int J Clin Pharmacol Ther"}],"container-title":["BMC Family Practice"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2296-7-69\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2296-7-69.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2296-7-69","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2296-7-69.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T09:45:29Z","timestamp":1548236729000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcfampract.biomedcentral.com\/articles\/10.1186\/1471-2296-7-69"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11,23]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["200"],"URL":"https:\/\/doi.org\/10.1186\/1471-2296-7-69","relation":{},"ISSN":["1471-2296"],"issn-type":[{"value":"1471-2296","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,11,23]]},"article-number":"69"}}